Last updated on August 24th, 2026 at 06:48 pm
The 10 symptoms of lung cancer are:
(1) persistent worsening cough, (2) shortness of breath or wheezing, (3) coughing up blood, (4) chest pain, (5) unexplained weight loss, (6) loss of appetite, (7) swollen lymph nodes in the neck or armpit, (8) blood clots in the body, (9) generalised muscle weakness, and (10) right-side abdominal pain indicating liver involvement.
When detected at Stage I, the 5-year survival rate reaches 92–95%. By Stage IV, it falls below 10%. “Early detection of these symptoms is key to a healthy recovery and significantly improves the 5-year survival rate,” says Dr. Ramakant Deshpande, Chief of Thoracic Surgical Oncology, Asian Institute of Oncology.
Introduction
Lung cancer is the leading cause of cancer-related mortality worldwide, and India is experiencing a troubling demographic shift in its patient profile.
“Lung cancer is developed by inhaling carcinogens either via polluted air or smoking, but people who smoke have 30 times more chances of developing lung cancer. Twenty years back, the average age of developing lung cancer was 50-60 years in India, which has come down to 40 years now. At that time, women were not among lung cancer patients, but now they form a significant chunk of lung cancer patients,” informs Dr. Ramakant Deshpande.
What makes lung cancer particularly dangerous is that it rarely causes symptoms in its earliest – and most curable – stages. By the time most patients notice something is wrong, the disease has often already progressed to Stage III or IV. Understanding which symptoms to watch for, and acting on them immediately, is the most powerful tool available to patients and families today.
The 10 Most Critical Symptoms of Lung Cancer – Explained by Dr. Ramakant Deshpande
1. Persistent, Worsening Cough (Hacking Cough)
A dry cough that persists for more than two months and continues to worsen is among the most common early indicators of lung cancer, occurring in approximately 65–75% of diagnosed patients.
Unlike a cough from a cold or respiratory infection, a lung-cancer-related cough does not resolve on its own and typically becomes more frequent and severe over time.
“Even if you are a nonsmoker and have a dry cough with other symptoms, it could be a serious lung infection or cancer.” — Dr. Ramakant Deshpande
Smokers should pay particular attention to any change in the character of their existing smoker’s cough – a shift from a familiar pattern to something more persistent, productive, or painful warrants immediate medical evaluation.
2. Shortness of breath (Dyspnea) or Wheezing
Difficulty breathing – medically termed dyspnea – occurs in approximately 60% of lung cancer patients and can develop even when a tumour is still relatively small.
The mechanism is direct: a tumour growing within or adjacent to an airway narrows the passage through which air must travel, creating resistance. When a tumour triggers fluid accumulation in the pleural space (pleural effusion), the lungs cannot expand fully, compounding the breathlessness.
Wheezing – a whistling or high-pitched sound during breathing – occurs when this narrowing is partial rather than complete. It is frequently misattributed to asthma or allergies, particularly in patients with no prior respiratory history.
Do not dismiss shortness of breath or wheezing as allergies or asthma without ruling out a lung pathology through imaging.
3. Coughing Up Blood (Haemoptysis)
Haemoptysis – coughing up blood or blood-streaked mucus – is one of the most alarming symptoms of lung cancer and demands immediate medical attention without exception.
It occurs in approximately 7–10% of lung cancer cases at initial presentation, though it is more common in centrally located tumours such as squamous cell carcinoma.
Even a single episode of coughing up blood, regardless of the amount, is a red-flag symptom that requires same-day medical evaluation.
4. Chest Pain
Chest pain associated with lung cancer typically presents as a dull, persistent ache that may worsen with deep breathing, coughing, or laughing – distinguishing it from cardiac chest pain, which is more often acute and crushing.
The pain arises when a tumour invades the chest wall, ribs, or the pleura (the lining surrounding the lungs). In advanced cases, pain may radiate to the shoulder, back, or arm – a pattern associated with Pancoast tumours that develop at the lung’s apex.
Proper diagnosis by an expert oncologist is essential, particularly when the pain is localised, persistent, or progressively worsening over time.
5. Unexplained Weight Loss
A sudden, unexplained loss of more than 5% of body weight over six to twelve months – without any change in diet or exercise – is a recognised warning sign across multiple cancer types, including lung cancer.
In lung cancer, this occurs because malignant cells consume disproportionate amounts of energy (a process known as cachexia), and because the body mounts an inflammatory immune response that further accelerates caloric expenditure. If you are not on a diet or exercise programme and notice significant, unintended weight changes, consult your doctor immediately.
6. Loss of appetite
Anorexia – the medical term for loss of appetite – is reported by a significant majority of lung cancer patients as disease progresses. At advanced stages, approximately 90% of patients report appetite loss.
This reduction in appetite compounds the weight loss described above, creating a cycle of malnutrition that weakens the body’s ability to withstand cancer treatment. Early nutritional intervention – working with an oncology dietitian – is an important and often overlooked component of lung cancer care.
7. Swollen Lymph Nodes in the Neck or Armpit
A palpable lump or swelling in the neck or armpit that persists for more than two weeks is a potential indicator that lung cancer has spread to the regional lymph nodes – a process known as lymphatic metastasis.
The supraclavicular lymph nodes (located just above the collarbone) are a particularly significant site: their enlargement in the context of other respiratory symptoms is a recognised red flag requiring urgent investigation. Immediate medical attention is crucial for biopsy and further staging.
8. Blood Clots (Venous Thromboembolism)
Lung cancer – particularly adenocarcinoma – is among the malignancies most strongly associated with venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE).
Cancer cells release procoagulant substances that activate the clotting cascade, while tumour compression of blood vessels further disrupts normal blood flow. Blood clots that migrate to the lungs (pulmonary embolism) can be immediately life-threatening and require urgent emergency intervention.
Warning signs of a blood clot include: leg pain or swelling (DVT), sudden onset of chest pain, rapid heart rate, or difficulty breathing (PE).
9. Generalised Muscle Weakness
Muscle weakness – particularly affecting the lower limbs and presenting with difficulty climbing stairs, rising from a chair, or sustained walking – is frequently associated with small-cell lung cancer (SCLC).
In SCLC, weakness can occur through a paraneoplastic syndrome: the immune system, in attempting to attack the tumour, inadvertently produces antibodies that damage the nervous system and neuromuscular junction.
This symptom – Lambert-Eaton Myasthenic Syndrome (LEMS) – can actually precede a formal lung cancer diagnosis, making it an important early diagnostic clue when accompanied by fatigue and other respiratory symptoms.
10. Right-Side Abdominal Pain or Jaundice (Liver Involvement)
Discomfort or pain in the right side of the abdomen, yellowing of the skin and whites of the eyes (jaundice), or a visibly swollen abdomen are signs that lung cancer may have metastasised to the liver – a relatively common site of distant spread, particularly in late-stage NSCLC and SCLC.
The liver lies under the right ribcage; when tumour deposits grow within it, they cause capsular distension, which produces the characteristic right-sided dull ache. Jaundice occurs when liver function is sufficiently compromised to impair bilirubin processing.
These symptoms should prompt same-day specialist consultation. Lung cancer that has spread beyond the lungs may also lead to nausea, headaches, neurological symptoms, or bone pain depending on the site of metastasis.
“In case of persistent symptoms, a person must seek a doctor. Smoking, chewing tobacco, or even e-cigarettes that contain nicotine may cause lung cancer,” warns Dr. Ramakant Deshpande.
Lung Cancer Symptoms by Stage – What to Expect at Each Stage
The following table maps which symptoms are most likely to appear at each stage of lung cancer. Note that Stage I is frequently asymptomatic – which is why screening matters. Evidence level: human clinical staging data (IASLC guidelines).
| Stage | Typical Presentation | Common Symptoms | 5-Year Survival |
| Stage I | Tumour confined to lung, <3cm | Often none; occasional cough | 92–95% |
| Stage II | Tumour larger or nodes involved locally | Persistent cough, mild dyspnea, fatigue | 53–60% |
| Stage III | Regional lymph node spread | Chest pain, weight loss, hoarseness, haemoptysis | 26–36% |
| Stage IV | Distant metastasis (liver, brain, bone) | All 10 symptoms possible + bone pain, headaches, jaundice | <10% |
Source: International Association for the Study of Lung Cancer (IASLC) staging guidelines. Survival figures represent 5-year relative survival rates by stage.
NSCLC vs. SCLC – Do Symptoms Differ?
Lung cancer is not a single disease. The two major categories — Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) — behave differently and can present with subtly different symptom profiles. Understanding this distinction can help clinicians reach a faster, more accurate diagnosis.
| Feature | NSCLC (80–85% of cases) | SCLC (15–20% of cases) |
| Growth rate | Slower growing | Fast-growing, spreads early |
| Typical location | Peripheral lung (adenocarcinoma) or central (squamous cell) | Central airways |
| Hallmark symptoms | Cough, dyspnea, weight loss | Muscle weakness (LEMS), cough, rapid weight loss |
| Haemoptysis likelihood | More common (squamous cell) | Less common at presentation |
| Paraneoplastic syndromes | Less frequent | More frequent (LEMS, SIADH, Cushing’s) |
The Case for Early Detection – Why Acting on Symptoms Immediately Saves Lives
Lung cancer in advanced stages is very difficult to cure, and treatments are often directed at reducing symptoms and offering a better quality of life rather than achieving a cure. But early detection fundamentally changes this picture.
At Stage I, the 5-year survival rate reaches 92 – 95%. By Stage IV, it falls below 10%. The difference between these outcomes is – in many cases – a matter of how quickly a patient acted on their symptoms.
Low-Dose CT (LDCT) Screening: The Standard of Care
Low-dose CT (LDCT) scanning is the only imaging modality proven through large-scale randomised trials to reduce lung cancer mortality in high-risk populations. Unlike chest X-rays, which can miss early-stage tumours smaller than 1cm, LDCT can detect lesions as small as a few millimetres – before symptoms appear.
Who Should Be Screened? (USPSTF & Indian Context)
The US Preventive Services Task Force (USPSTF) recommends annual LDCT screening for individuals who meet all three of the following criteria:
- Are current smokers or have quit within the past 15 years
- Have a smoking history of at least 20 pack-years (one pack per day for 20 years, or equivalent)
- Are between the ages of 50 and 80
In the Indian context, the National Cancer Grid (NCG) and oncologists such as Dr. Deshpande note that the age of onset is now as low as 40 in Indian patients, and non-smoker lung cancer – particularly among Indian women – is rising.
Indian patients who are non-smokers but have prolonged exposure to indoor air pollution (biomass fuel cooking smoke), occupational carcinogens, or a family history of lung cancer should discuss screening eligibility with their oncologist regardless of USPSTF criteria.
Line of Treatment for Lung Cancer
Lung cancer treatment involves a multidisciplinary approach, including medical and surgical oncologists and radiation therapists.
- Early-Stage Cancer: Surgery is often the first line of treatment, followed by chemotherapy or radiation therapy.
- Advanced Cases: Targeted therapies and immunotherapy are used to slow disease progression and improve quality of life.
- Supportive Care: Psycho-oncology consultations help patients prepare for treatments and manage side effects.
When to Contact MedicoExperts – Getting a Specialist Opinion
If you or a family member is experiencing any of the ten symptoms described above – particularly if more than two symptoms are present simultaneously, or if a single symptom has persisted for more than two weeks – the right next step is a specialist evaluation, not a watch-and-wait approach.
MedicoExperts connects patients with a comprehensive Tumour Board — a multidisciplinary team of medical oncologists, surgical oncologists, and radiation oncologists — who evaluate your case together and recommend the most appropriate diagnostic workup and treatment pathway.
For more information, please email us your medical query with reports, by Call/WhatsApp us at +919769516280
Doctor Speaks
Dr. Ramakant Deshpande
MS; FICS; FAIS; DHA
Experience: 31+ years
Chief of Thoracic Surgical Oncology, Asian Institute of Oncology, Padmashree award by the President of India in 2014
Frequently Asked Questions About Lung Cancer Symptoms
Q1. What are the early signs of lung cancer, and why are they easy to miss?
The earliest signs of lung cancer include a persistent dry cough, mild shortness of breath, and unusual fatigue – symptoms that are so commonly associated with minor respiratory infections or lifestyle factors that most patients dismiss them for months.
Q2. Can lung cancer symptoms be mistaken for other illnesses?
Yes – and this is one of the primary reasons lung cancer is diagnosed late. A persistent cough is routinely attributed to bronchitis, postnasal drip, or acid reflux. Shortness of breath is often treated as asthma. Chest pain is frequently investigated as a cardiac or musculoskeletal issue. Fatigue is dismissed as stress or anaemia. A thorough medical evaluation is crucial for accurate diagnosis.
Q3. How can I reduce my risk of lung cancer?
Avoid smoking, limit exposure to pollutants, and maintain a healthy lifestyle. Regular screenings for high-risk individuals are also recommended.
Q4. Is lung cancer treatable if detected early?
Yes, early detection increases the likelihood of successful treatment and long-term survival.
Q5. Do lung cancer symptoms differ between smokers and non-smokers?
The fundamental symptom list is the same for smokers and non-smokers, but the clinical context differs significantly. Non-smokers who develop lung cancer – a group that accounts for 15–20% of all lung cancer cases and is growing in India – are more likely to have adenocarcinoma, which tends to develop in the peripheral lung tissue and may present with milder, more insidious symptoms such as gradual dyspnea and fatigue rather than the prominent cough associated with centrally located tumours. Non-smokers are also less likely to be on any screening programme, making late detection more common. Any non-smoker with two or more persistent respiratory symptoms should seek specialist evaluation without assuming they are low-risk.
Q6. Are lung cancer symptoms different in women?
Emerging data and the clinical experience of specialists like Dr. Ramakant Deshpande indicate that women in India are increasingly presenting with lung cancer despite having no smoking history. In women, adenocarcinoma – a type of Non-Small Cell Lung Cancer – is disproportionately common, and its early symptoms are frequently subtle: a mild progressive breathlessness, occasional dry cough, and fatigue. Because these symptoms are non-specific and women are not considered a traditional high-risk group, diagnosis is often delayed. Any woman experiencing unexplained respiratory symptoms – particularly with a history of indoor air pollution exposure from biomass cooking fuels – should not defer seeking a specialist opinion.
Q7. How is lung cancer diagnosed after symptoms appear?
When a patient presents with symptoms suggestive of lung cancer, the diagnostic pathway typically begins with a chest X-ray and, if an abnormality is detected or clinical suspicion remains high, a Low-Dose CT (LDCT) scan of the thorax. CT scanning provides significantly greater detail, detecting lesions that X-rays miss entirely. A positive or suspicious CT finding is followed by a biopsy – which may be performed via bronchoscopy, CT-guided needle biopsy, or surgical resection – to confirm the diagnosis histologically. Staging investigations, including PET-CT scanning and brain MRI, are then used to determine the extent of disease spread. At MedicoExperts, patients are evaluated by a comprehensive Tumour Board for a unified, multidisciplinary diagnostic and treatment recommendation.
- Larkin J et al. Lung Cancer: Clinical Presentation and Diagnosis. Am Fam Physician. 2018;97(12):789–796. https://pubmed.ncbi.nlm.nih.gov/29313654/
- Ruano-Raviña A et al. Lung cancer symptoms at diagnosis: results of a nationwide registry study. ESMO Open. 2020;5(4):e001021. DOI: 10.1136/esmoopen-2020-001021
- de Koning HJ et al. Reduced Lung-Cancer Mortality with Volume CT Screening (NELSON Trial). N Engl J Med. 2020;382(6):503–513. DOI: 10.1056/NEJMoa1911793
- NLST Research Team. Reduced Lung-Cancer Mortality with Low-Dose CT Screening. N Engl J Med. 2011;365(5):395–409. DOI: 10.1056/NEJMoa1102873
- Noronha V et al. Epidemiology of lung cancer in India: focus on smokers vs. non-smokers. Indian J Cancer. 2016;53(2):329–333. DOI: 10.4103/0019-509X.98925
- Ivanovski T, Miralles F. Lambert-Eaton Myasthenic Syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis. 2019;9:27–37. DOI: 10.2147/DNND.S192588
- American Cancer Society. Lung Cancer Survival Rates (SEER data). Updated February 2025. https://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/survival-rates.html
The content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Symptoms, risk factors, and outcomes vary between individuals – always consult a qualified oncologist before making any health decisions. Survival statistics are population-level data from the NCI SEER database and are not predictive of individual outcomes.
Medically Reviewed by MedicoExperts Editorial & Clinical Review Board
